Assembly Biosciences, Inc. (ASMB) vs NRC Health (NRC)
A side-by-side comparison of Assembly Biosciences, Inc. and NRC Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
NRC
NRC Health
$20.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ASMB vs NRC
growth of $100 · dividends reinvested · last 10yASMB -76.4% (-13.4%/yr)NRC +62.0% (+4.9%/yr)NRC compounded faster over this window
Log scale — wide-divergence pair
ASMB NRC
ASMB vs NRC: by the numbers
- •NRC is the larger company ($468M vs $451M market cap).
- •ASMB trades at the lower trailing earnings multiple (41.35 vs 82.33 P/E), one valuation lens rather than an overall verdict.
- •NRC is profitable (4.18% net margin) while ASMB runs a net loss (-0.06%).
- •Both shrank revenue over the past five years; NRC's decline was smaller (-0.02% vs -1.78% CAGR).
- •NRC pays a dividend (2.89% yield), while ASMB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ASMB | NRC |
|---|---|---|
| P/E ratio | 41.35 | 82.33 |
| Forward P/E | N/A | 23.61 |
| P/S ratio | 6.02 | 3.35 |
| P/B ratio | 1.47 | 71.51 |
| EV / EBITDA | N/A | 23.75 |
| FCF yield | N/A | 4.62% |
Profitability
| Metric | ASMB | NRC |
|---|---|---|
| Gross margin | 99.82% | 56.33% |
| Operating margin | -11.75% | 10.53% |
| Net margin | -0.06% | 4.18% |
| ROE | -0.01% | 89.43% |
| ROIC | -2.86% | 8.75% |
Dividends
| Metric | ASMB | NRC |
|---|---|---|
| Dividend yield | N/A | 2.89% |
| Payout ratio | N/A | 237.72% |
Growth (annualized)
| Metric | ASMB | NRC |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | -0.02% |
| EPS CAGR (5Y) | N/A | -18.88% |
| FCF CAGR (5Y) | N/A | -14.35% |
| Total return CAGR (5Y) | -10.66% | -11.49% |
Frequently asked
- Which has the lower trailing P/E, ASMB or NRC?
- ASMB has the lower trailing P/E: ASMB trades at 41.35 and NRC at 82.33. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ASMB or NRC?
- Neither grew: over the past five years both shrank revenue, with NRC's decline the smaller — ASMB at a -1.78% CAGR versus NRC at -0.02%.
- Does ASMB or NRC pay a bigger dividend?
- NRC pays a dividend (2.89% yield), while ASMB has no payments in the available dividend history.
- Is ASMB or NRC more profitable?
- NRC runs the higher net margin — ASMB at -0.06% versus NRC at 4.18%.
- How have ASMB and NRC total returns compared?
- Over the past 10 years, ASMB delivered -13.41% and NRC delivered 4.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioNRC Health P/E ratioNRC Health dividend yieldAssembly Biosciences ROENRC Health ROEAssembly Biosciences operating marginNRC Health operating marginAssembly Biosciences revenue growthNRC Health revenue growthAssembly Biosciences free cash flowNRC Health free cash flow
Assembly Biosciences & NRC Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.